Lyme Disease - Pipeline Review, H1 2018

Publisher Name :
Date: 23-Jan-2018
No. of pages: 40
Inquire Before Buying

Lyme Disease - Pipeline Review, H1 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lyme Disease - Pipeline Review, H1 2018, provides an overview of the Lyme Disease (Infectious Disease) pipeline landscape.

Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factors include age, gender and geographic locations. Treatment includes antibiotics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Lyme Disease - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Lyme Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Lyme Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 2, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively.

Lyme Disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Lyme Disease (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Lyme Disease (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Lyme Disease (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Lyme Disease (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Lyme Disease (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Lyme Disease (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Lyme Disease (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Lyme Disease - Pipeline Review, H1 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Lyme Disease - Overview
Lyme Disease - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Lyme Disease - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Lyme Disease - Companies Involved in Therapeutics Development
LondonPharma Ltd
NovoBiotic Pharmaceuticals LLC
Valneva SE
Lyme Disease - Drug Profiles
azithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
desloratadine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lyme disease vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lyme disease vaccine 2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibodies to Inhibit Outer Surface Protein A for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody to Inhibit CRASP1 for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VLA-15 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Lyme Disease - Dormant Projects
Lyme Disease - Product Development Milestones
Featured News & Press Releases
Jul 24, 2017: VALNEVA Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15
Dec 09, 2016: Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate
Jul 12, 2016: European Investment Bank Grants Valneva a EU25 Million Loan to Fund R&D Activities
Mar 24, 2016: VALNEVA to present at the 16th World Vaccine Congress in Washington D.C.
Jan 22, 2013: Agile Sciences Receives Grant From Bay Area Lyme Fund
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Lyme Disease, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Lyme Disease - Pipeline by LondonPharma Ltd, H1 2018
Lyme Disease - Pipeline by NovoBiotic Pharmaceuticals LLC, H1 2018
Lyme Disease - Pipeline by Valneva SE, H1 2018
Lyme Disease - Dormant Projects, H1 2018

List of Figures
Number of Products under Development for Lyme Disease, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Targets, H1 2018
Number of Products by Stage and Targets, H1 2018
Number of Products by Mechanism of Actions, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
  • Global Ampicillin Market Growth 2020-2025
    Published: 27-Feb-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Ampicillin market will register a 2.7% CAGR in terms of revenue, the global market size will reach $ 170.4 million by 2025, from $ 153.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ampicillin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Ampicillin market by type, application, key m......
  • Global Miconazole Nitrate Market Research Report 2020
    Published: 26-Feb-2020        Price: US 2900 Onwards        Pages: 93
    This report focuses on Miconazole Nitrate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Miconazole Nitrate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered i......
  • Global Drugs for Toxoplasmosis Market Research Report 2020
    Published: 21-Feb-2020        Price: US 2900 Onwards        Pages: 92
    This report focuses on Drugs for Toxoplasmosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Toxoplasmosis market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer......
  • Global Antibiotics Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 20-Feb-2020        Price: US 2980 Onwards        Pages: 76
    Snapshot The global Antibiotics market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Antibiotics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, bes......
  • Global Tigecycline Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 19-Feb-2020        Price: US 2980 Onwards        Pages: 83
    Snapshot The global Tigecycline market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Tigecycline by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, bes......
  • Global Tigecycline Market Data Survey Report 2015-2025
    Published: 19-Feb-2020        Price: US 1500 Onwards        Pages: 62
    Summary The global Tigecycline market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales d......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth 2020-2025
    Published: 18-Feb-2020        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Drugs for Herpes Labialis (Oral Herpes) market will register a 5.3% CAGR in terms of revenue, the global market size will reach $ 2717.6 million by 2025, from $ 2211.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Drugs for Herpes Labialis (Oral Herpes) business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth op......
  • Global Cefazolin Sodium Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 15-Feb-2020        Price: US 2980 Onwards        Pages: 86
    Snapshot The global Cefazolin Sodium market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cefazolin Sodium by product, region and application, in addition, this report introduces market competition situation among the vendors and company pr......
  • Global Famciclovir Market Research Report 2020
    Published: 14-Feb-2020        Price: US 2900 Onwards        Pages: 119
    This report focuses on Famciclovir volume and value at global level, regional level and company level. From a global perspective, this report represents overall Famciclovir market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs